Grove Bank & Trust’s Verastem VSTM Stock Holding History

Grove Bank & Trust’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8	Closed	-$48	–	914
2025 Q1	$48	Buy	+8	New	+$49	﹤0.01%	841

Other funds holding VSTM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Grove Bank & Trust's VSTM Position: Q2 2025 in Review

Grove Bank & Trust sold out of Verastem (VSTM) in Q2 2025, closing a stake of 8 shares — an estimated $48 sold.

Grove Bank & Trust first reported a position in VSTM in Q1 2025 and held it in 1 quarter. The position peaked at $48 in Q1 2025. 110 funds tracked by Wall St. Rank hold VSTM as of Q2 2025.

Grove Bank & Trust reported no remaining Verastem position as of Q2 2025 after selling out during the quarter.
Grove Bank & Trust sold 8 Verastem shares in Q2 2025, an estimated $48.
Grove Bank & Trust first reported a position in Verastem in Q1 2025 and held it in 1 quarter.
Grove Bank & Trust's Verastem position peaked at $48 in Q1 2025.
110 funds tracked by Wall St. Rank held Verastem as of Q2 2025.

Based on Grove Bank & Trust's 13F filing for Q2 2025, filed 11 Jul 2025.